Related Experiment Video
Updated: Apr 26, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
A standardized bleeding risk score aligns anticoagulation choices with current evidence
Arielle S Berger1, Andrew S Dunn, Amy S Kelley
1From the *Department of Medicine, Mount Sinai and University Health Network Hospitals, Toronto, ON, Canada; †Department of Medicine, Mount Sinai Hospital, New York,NY; ‡Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, NY; and §Geriatric Research Education and Clinical Centers, James J Peters VA Medical Center, Bronx, New York, NY.
The HAS-BLED score improved appropriate oral anticoagulation decisions in elderly patients with atrial fibrillation by 18%. This tool helps physicians balance stroke risk and bleeding complications for better patient care.
Area of Science:
- Cardiology
- Geriatrics
- Clinical Decision Support
Background:
- Atrial fibrillation (AF) is a common arrhythmia in the elderly, significantly increasing stroke risk.
- Oral anticoagulation (OAC) effectively reduces stroke risk by 60% but is often underprescribed.
- The HAS-BLED score aids in predicting bleeding complications associated with OAC.
Purpose of the Study:
- To evaluate if the HAS-BLED score improves the appropriateness of OAC decisions in elderly AF patients.
- To assess the impact of the HAS-BLED score on physician decision-making regarding anticoagulation.
Main Methods:
- A survey with clinical vignettes was administered to physicians.
- Physicians were randomized to receive the survey with or without the HAS-BLED score and bleeding risk estimates.
- Appropriate anticoagulation was defined as minimizing stroke and major bleeding risks.
Main Results:
- Physicians using the HAS-BLED score were 18% more likely to make appropriate anticoagulation decisions (74% vs. 56%).
- The score facilitated appropriate anticoagulation initiation and cessation based on risk-benefit analysis.
- Physicians demonstrated poor accuracy in estimating stroke (42%) and bleeding (31%) risks.
Conclusions:
- The HAS-BLED score significantly enhances appropriate OAC prescribing in elderly AF patients.
- Further research is recommended to integrate the HAS-BLED score into real-time clinical practice.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis IV: Nursing Management
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

